Lumera Receives Order from BRI for a ProteomicProcessor Biosensor
News May 16, 2006
"Dr. Jacques Banchereau's work at the Institute is cutting-edge research in the field of Immunology which focuses on cancer vaccines, autoimmune and infectious diseases, and organ transplantation," said Ron Dudek, Product Development Manager, Bioscience Business Unit.
"We look forward to demonstrating the ProteomicProcessor's high-throughput measurement capability in Dr. Banchereau's multi-faceted program."
"Our label-free technology coupled with our NanoCapture™ high-density microarrays should lower the cost and increase the speed of data acquisition for the life sciences, drug discovery and translational medicine researchers."
Dr. Banchereau's team at Baylor Research Institute, a component of Baylor Health Care System in Dallas, plans to use the ProteomicProcessor™ to measure serum protein levels.
"The strength of this instrument for us is the ability to look at many serum protein levels at the same time without having to label the proteins first," states Dr. Banchereau.
Computation and Chemistry Combine to Create World-First Auxetic ProteinNews
A team of chemists at the University of California, San Diego (UCSD) has now designed a two-dimensional protein crystal that toggles between states of varying porosity and density. This is a first in biomolecular design that combined experimental studies with computation done on supercomputers. The research, published in April 2018 in Nature Chemistry, could help create new materials for renewable energy, medicine, water purification, and more.
Fructose Formula Poses Risk to Babies With Metabolic DisorderNews
Babies with inherited intolerance of fructose face a risk of acute liver failure if they are fed certain widely available formulas containing fructose, pediatricians and geneticists are warning. Baby formula manufacturers should remove fructose or sucrose, or explicitly label their products to allow parents to avoid those sweeteners if necessary, the doctors say.